The Phase 1 study is a single-ascending dose trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of LRK-4189 in healthy volunteers. The United Kingdom-based study expects ...

There are moments in a nation's professional journey when a qualification doesn't just open doors--it opens horizons. Today, ...

Yet amid this exodus, Nigeria seems to be losing more than it gains. The challenge, however, is not migration itself, but how ...

"Effective Tuesday, Amazon launched its Trainium3 chip, which is part of the revenue ramp called out by Marvell back in ...

Workers who pair their expertise with AI’s capabilities will be the ones who are able to turn passion projects into real ...

Discover mōcean's new approach to energy drinks, focusing on wellness with ingredients like Shiso, Ashwagandha, and ...

Despite big-cap tech stocks growing to represent over one-third of the S&P 500, Bakshi points out that members of the mag 7 ...

OpenAI may also get payouts from Thrive Holdings’ future returns, the FT wrote, citing its anonymous source. It’s the latest ...

Across the country, other schools besides Wharton are also catching the AI wave. One is Vanderbilt University in Tennessee, ...

New research programmes addressing national priorities and creating economic value will be launched. Read more at ...

In AI-driven environments, batteries are no longer just emergency backup. They’re the first line of defense – absorbing ...

Success in 2025 looks very different from the traditional paths of the past. A new wave of forward thinking entrepreneur ...